Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cancer of the Pancreas Screening Study (CAPS 3) (CAPS 3)

This study has been completed.
Sponsor:
Collaborators:
Lustgarten Foundation
National Cancer Institute (NCI)
Information provided by (Responsible Party):
MCanto, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00438906
First received: February 20, 2007
Last updated: September 7, 2016
Last verified: September 2016